TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,712.57+0.28%Nasdaq 10029,490.28−0.13%Nifty 5023,080.55+0.84%Sensex74,537.20+0.93%KSE-100165,151.64+0.00%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.47−0.29%NYSE:TSM$425.08+1.16%NSE:RELIANCE₹1,226.00+2.00%KAR:OGDCRs 300.01+0.18%Gold$4,119.67−0.14%Brent$110.28+1.09%BTC$82,707.66−0.28%ETH$2,441.99−0.19%DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,712.57+0.28%Nasdaq 10029,490.28−0.13%Nifty 5023,080.55+0.84%Sensex74,537.20+0.93%KSE-100165,151.64+0.00%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.47−0.29%NYSE:TSM$425.08+1.16%NSE:RELIANCE₹1,226.00+2.00%KAR:OGDCRs 300.01+0.18%Gold$4,119.67−0.14%Brent$110.28+1.09%BTC$82,707.66−0.28%ETH$2,441.99−0.19%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Open 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Mesoblast Ltd · Overview · TradingHolo

Markets › United States › NAS › MESO

M

Mesoblast Ltd

NAS:MESOHealthcareNASDAQ:NBINASDAQ:NCX

$11.95−10.02%At closeAt close · Tue 20 Oct · ≈ AED 43.89 · Market cap $1.8B · Next earnings Thu 4 Mar

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−10.0%

1M

−21.0%

3M

−27.2%

6M

−28.1%

1Y

−33.9%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

MESO −10.02% today

✦ This week in three lines

No written digest yet for MESO. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR +74.5%

Valuation

P/E vs sector−31.1× vs −1.7×

Price / Book vs sector3.2× vs 2.0×

Price / Sales vs sector14.9× vs 3.9×

Price / Free cash flow vs sector−26.4× vs −1.5×

Forecasts

7 buy0 hold0 sell7 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 84 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All MESO news →

SEMesoblast wins FDA nod for new potency assay for Ryoncil

seekingalpha · 27 d ago

BEMesoblast Targets $10 Billion Market With Regenerative Back Pain Treatment

Benzinga · 65 d ago

GLMesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

GlobeNewsWire · 65 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$1.8B

P/E−31.1×

Dividend yield0.0%

52-week range$11.89 – $21.50

Avg volume (20d)280,470

Shares outstanding129,696,087

Beta0.81

Short interest4.0% of float

Next earningsThu 4 Mar

Radar Score

—

Value—

Quality—

Momentum—

Income—

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including…

Sector

Healthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

56.6×−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

22.8×−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

118.2×−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

30.3×+1.36%